KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 136 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $79,000 | -96.0% | 16,921 | -94.0% | 0.00% | -100.0% |
| Q3 2017 | $1,997,000 | +62.9% | 281,300 | +65.9% | 0.00% | +50.0% |
| Q2 2017 | $1,226,000 | +57.2% | 169,579 | +34.0% | 0.00% | +100.0% |
| Q1 2017 | $780,000 | -26.1% | 126,568 | -29.8% | 0.00% | -50.0% |
| Q4 2016 | $1,056,000 | +618.4% | 180,271 | +551.2% | 0.00% | – |
| Q3 2016 | $147,000 | -24.2% | 27,683 | -5.4% | 0.00% | – |
| Q2 2016 | $194,000 | -84.0% | 29,252 | -88.8% | 0.00% | -100.0% |
| Q1 2016 | $1,215,000 | +53.0% | 260,220 | +65.5% | 0.00% | +100.0% |
| Q4 2015 | $794,000 | +90.4% | 157,225 | +32.6% | 0.00% | 0.0% |
| Q3 2015 | $417,000 | -77.5% | 118,561 | -36.2% | 0.00% | -66.7% |
| Q2 2015 | $1,853,000 | +1119.1% | 185,720 | +1458.7% | 0.00% | – |
| Q1 2015 | $152,000 | -87.9% | 11,915 | -86.5% | 0.00% | -100.0% |
| Q4 2014 | $1,254,000 | +68.1% | 88,579 | +63.3% | 0.00% | +100.0% |
| Q3 2014 | $746,000 | +44.3% | 54,239 | +61.5% | 0.00% | 0.0% |
| Q2 2014 | $517,000 | -58.6% | 33,588 | -54.2% | 0.00% | -50.0% |
| Q1 2014 | $1,250,000 | -86.5% | 73,341 | -89.7% | 0.00% | -84.6% |
| Q4 2013 | $9,262,000 | +81.9% | 715,273 | +41.9% | 0.01% | +62.5% |
| Q3 2013 | $5,091,000 | -1.5% | 504,067 | -27.1% | 0.01% | -20.0% |
| Q2 2013 | $5,167,000 | – | 691,624 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |